KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Interest & Investment Income (2016 - 2026)

West Pharmaceutical Services has reported Interest & Investment Income over the past 18 years, most recently at $5.1 million for Q1 2026.

  • Quarterly Interest & Investment Income rose 24.39% to $5.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Mar 2026, up 5.71% year-over-year, with the annual reading at $17.5 million for FY2025, 10.71% down from the prior year.
  • Interest & Investment Income was $5.1 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $5.1 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $9.4 million in Q4 2023 and troughed at $300000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $4.7 million (2025), against an average of $4.4 million.
  • Biggest five-year swings in Interest & Investment Income: surged 1500.0% in 2023 and later plummeted 48.94% in 2024.
  • Tracing WST's Interest & Investment Income over 5 years: stood at $2.9 million in 2022, then skyrocketed by 224.14% to $9.4 million in 2023, then plummeted by 48.94% to $4.8 million in 2024, then rose by 6.25% to $5.1 million in 2025, then changed by 0.0% to $5.1 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $5.1 million, $5.1 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.